Compare OPTX & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPTX | CDXS |
|---|---|---|
| Founded | 1981 | 2002 |
| Country | United States | United States |
| Employees | 159 | N/A |
| Industry | Blank Checks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.0M | 256.3M |
| IPO Year | N/A | 2008 |
| Metric | OPTX | CDXS |
|---|---|---|
| Price | $10.88 | $2.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 833.7K | ★ 939.7K |
| Earning Date | 03-31-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $138,590,000.00 |
| Revenue This Year | N/A | $7.73 |
| Revenue Next Year | N/A | $14.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.30 |
| 52 Week Low | $1.18 | $0.96 |
| 52 Week High | $14.92 | $3.87 |
| Indicator | OPTX | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 51.19 |
| Support Level | $5.93 | $2.41 |
| Resistance Level | $11.83 | $2.69 |
| Average True Range (ATR) | 1.53 | 0.15 |
| MACD | -0.17 | -0.00 |
| Stochastic Oscillator | 25.16 | 63.44 |
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.